VS
stockvs
Go to ScreenerHub
MRK

MRK vs NVO

NVO

In the past 12 months, MRK returned +22% while NVO lost 52%.

MRK
MRK

Merck & Co., Inc.

$115.42
-5.1%(1M)
Market Cap285.4B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio15.97
ROE36.2%
P/B Ratio5.54
Dividend Yield2.8%
NVO
NVO

Novo Nordisk A/S

$38.58
-21.9%(1M)
Market Cap171.5B
Healthcare
Drug Manufacturers - General
DK
P/E Ratio10.78
ROE61.1%
P/B Ratio5.69
Dividend Yield4.7%
Performance Comparison

Historical returns across multiple timeframes

MRK leads 8/8
MRK

MRK

Merck & Co., Inc.

+21.8%

1Y Return

NVO

NVO

Novo Nordisk A/S

-51.9%

1Y Return

MRK
MRK
NVO
NVO

Short Term

1M-6M

MRK
+18.2%

Medium Term

YTD-1Y

MRK
+15.1%

Long Term

3Y-10Y

MRK
+66.0%

Valuation

Compare price multiples and valuation ratios

MRK: 1NVO: 4
MetricMRKNVOWinner
P/E Ratio

Price to earnings ratio

15.9710.78NVO
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

4.453.57NVO
P/B Ratio

Price to book ratio

5.545.69MRK
P/FCF Ratio

Price to free cash flow ratio

23.4219.66NVO
EV/EBITDA

Enterprise value to EBITDA

12.347.56NVO
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

MRK: 1NVO: 5
MetricMRKNVOWinner
Gross Margin

Gross profit margin

81.5%81.0%MRK
Operating Margin

Operating profit margin

41.2%41.3%NVO
Net Margin

Net profit margin

28.1%33.1%NVO
ROE

Return on equity

36.2%61.1%NVO
ROA

Return on assets

13.3%18.9%NVO
ROIC

Return on invested capital

20.8%29.5%NVO

Growth

Compare revenue and earnings growth rates

MRK: 2NVO: 4
MetricMRKNVOWinner
Revenue Growth (YoY)

Year-over-year revenue growth

1.3%2.3%NVO
Revenue Growth (3Y)

3-year revenue CAGR

3.1%18.9%NVO
Revenue Growth (5Y)

5-year revenue CAGR

9.4%18.5%NVO
EPS Growth (YoY)

Year-over-year EPS growth

8.0%1.8%MRK
EPS Growth (3Y)

3-year EPS CAGR

8.4%23.5%NVO
EPS Growth (5Y)

5-year EPS CAGR

21.2%20.7%MRK

Balance Sheet & Risk

Compare financial stability and debt levels

MRK: 4NVO: 1
MetricMRKNVOWinner
Debt/Equity

Debt to equity ratio

0.960.67NVO
Current Ratio

Current assets to current liabilities

1.540.80MRK
Quick Ratio

Quick assets to current liabilities

1.300.57MRK
Interest Coverage

EBIT to interest expense

28.3418.83MRK
Beta

Stock volatility vs market

0.260.27MRK
Summary
NVO wins 3-1

Valuation

NVO

Profitability

NVO

Growth

NVO

Balance Sheet

MRK

NVO is more attractively valued. NVO shows stronger profitability. NVO demonstrates better growth. MRK has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into MRK and NVO with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/MRK/vs/NVO" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare MRK vs NVO on stockvs.app
</a>